(Q43980473)

28 November 2017

title

Reduction in arterial stiffness with angiotensin II antagonist is comparable with and additive to ACE inhibition (English)

1 reference

28 November 2017

Azra Mahmud

1

1 reference

28 November 2017

John Feely

series ordinal

2

1 reference

28 November 2017

publication date

1 April 2002

1 reference

Journal of Clinical Hypertension

28 November 2017

published in

1 reference

28 November 2017

volume

15

1 reference

28 November 2017

issue

4 Pt 1

1 reference

28 November 2017

page(s)

321-325

1 reference

Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902313-5

Favourable effects on arterial wave reflection and pulse pressure amplification of adding angiotensin II receptor blockade in resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902313-5

Aortic input impedance in normal man: relationship to pressure wave forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902313-5

Changes in the derived central pressure waveform and pulse pressure in response to angiotensin II and noradrenaline in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902313-5

Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902313-5

Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902313-5

7 January 2021

Remodeling of Heart and Arteries by Chronic Converting Enzyme Inhibition in Spontaneously Hypertensive Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902313-5

7 January 2021

Antihypertensive effects and arterial haemodynamic alterations during angiotensin converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902313-5

7 January 2021

Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902313-5

7 January 2021

Additive effects of enalapril and losartan in (mREN-2)27 transgenic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902313-5

7 January 2021

Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902313-5

7 January 2021

Blockade of the renin-angiotensin-aldosterone system with combination angiotensin receptor antagonist and ACE inhibitor therapy: observations from Val-HeFT and CALM

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902313-5

7 January 2021

10.1016/S0895-7061(01)02313-5

Identifiers

DOI

1 reference

28 November 2017

1 reference